These findings suggest that TBX4 mutations may occur with or without skeletal abnormalities and whilst such mutations are mainly associated with childhood-onset PAH, the prevalence of PAH in adult TBX4 mutation carriers could be up to 3%, depending on the population studied. The gene discussed is TBX4; the disease is pulmonary arterial hypertension.